Hepatitis C-related cirrhosis: A predictor of diabetes after liver transplantation

Hepatology

Volumn 32, Issue 1, 2000, Pages 87-90

  Bigam, Dave L ^a   Pennington, Jason J ^a   Carpentier, Andre ^a   Wanless, Ian R ^a   Hemming, Alan W ^a   Croxford, Ruth ^b   Greig, Paul D ^a   Lilly, Leslie B ^a   Heathcote, Jenny E ^a   Levy, Gary A ^a   Cattral, Mark S ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHOLESTATIC HEPATITIS; DIABETES MELLITUS; DISEASE ASSOCIATION; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PREDICTION; PREVALENCE; PRIORITY JOURNAL;

EID: 0034234790     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.8270     Document Type: Article

References (28)

1. 1. Trail KC, McCashland TM, Larsen JL, Heffron TG, Stratta RJ, Langnas AN, Fox IJ, et al. Morbidity in patients with posttransplant diabetes mellitus following orthotopic liver transplantation. Liver Transpl Surg 1996;2:276-283.
2. 2. Stegall MD, Everson G, Schroter G, Bilir B, Karrer F, Kam I. Metabolic complications after liver transplantation. Transplantation 1995;60:1057-1060.
3. 3. Krentz AJ, Dousset B, Mayer D, McMaster P, Buckels J, Cramb R, Smith JM, et al. Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients. Diabetes 1993;42:1753-1759.
4. 4. Krentz AJ, Dmitrewski J, Mayer D, McMaster P, Buckels J, Dousset B, Cramb R, et al. Postoperative glucose metabolism in liver transplant recipients. A two-year prospective randomized study of cyclosporine versus FK506. Transplantation 1994;57:1666-1669.
5. 5. Jindal RM, Popescu I, Schwartz ME, Emre S, Boccagni P, Miller CM. Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients. Transplantation 1994;58:370-372.
6. 6. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994;344:423-428.
7. 7. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994;331:1110-1115.
8. 8. Fraser GM, Harman I, Meller N, Niv Y, Porath A. Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. Isr J Med Sci 1996;32:526-530.
9. 9. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. HEPATOLOGY 1999;29:328-333.
10. 10. Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo LI, Petrik J, O'Rahilly S, et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. HEPATOLOGY 1999;30:1059-1063.
11. 11. Knobler H, Stagnaro-Green A, Wallenstein S, Schwartz M, Roman SH. Higher incidence of diabetes in liver transplant recipients with hepatitis C. J Clin Gastroenterol 1998;26:30-33.
12. 12. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2000;23:S4-S19.
13. 13. Hemming AW, Greig PD, Cattral MS, Chung SW Lilly LB, Aljumah AA, Levy GA. A microemulsion formulation of cyclosporine without intravenous cyclosporine in liver transplantation. Transplantation 1996;62:1798-1802.
14. 14. Cattral MS, Hemming AW, Wanless IR, Al Ashgar H, Krajden M, Lilly L, Greig PD, et al. Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation. Transplantation 1999;67:1277-1280.
15. 15. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994;21:1135-1139.
16. 16. Navasa M, Bustamante J, Marroni C, Gonzalez E, Andreu H, Esmatjes E, Garcia-Valdecasas JC, et al. Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol 1996;25:64-71.
17. 17. Imagawa A, Itoh N, Hanafusa T, Oda Y, Waguri M, Miyagawa J, Kono N, et al. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis. J Clin Endocrinol Metab 1995;80:922-926.
18. 18. Haddad J, Deny P Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, Mal F, et al. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-323.
19. 19. Hadziyannis SJ. The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepat 1997;4:9-28.
20. 20. di Cesare E, Previti M, Russo F Brancatelli S, Ingemi MC, Scoglio R, Mazzu N, et al. Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis. Dig Dis Sci 1996;41:1672-1677.
21. 21. Fabris R Betterle C, Greggio NA, Zanchetta R, Bosi E, Biasin MR, Lalla F. Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis. J Hepatol 1998;28:514-517.
22. 22. Kingston ME, Ali MA, Atiyeh M, Donnelly RJ. Diabetes mellitus in chronic active hepatitis and cirrhosis. Gastroenterology 1984;87:688-694.
23. 23. Proietto J, Alford FP, Dudley FJ. The mechanism of the carbohydrate intolerance of cirrhosis. J Clin Endocrinol Metab 1980;51:1030-1036.
24. 24. Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. HEPATOLOGY 1994;19:616-627.
25. 25. Nolte W Hartmann H, Ramadori G. Glucose metabolism and liver cirrhosis. Exp Clin Endocrinol Diabetes 1995;103:63-74.
26. 26. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immuno-deficiency syndrome: specific detection of negative-strand viral RNA in various tissues. HEPATOLOGY 1998;28:1398-1401.
27. 27. Trail KC, Stratta RJ, Larsen JL, Ruby EI, Paul KD, Langnas AN, Donovan JP, et al. Results of liver transplantation in diabetic recipients. Surgery 1993;114:650-656.
28. 28. Shields PL, Tang H, Neuberger JM, Gunson BK, McMaster P. Pirenne J. Poor outcome in patients with diabetes mellitus undergoing liver transplantation. Transplantation 1999;68:530-535.